FIELD: medicine.
SUBSTANCE: technique is based on measuring a blood plasma interleukin IL-8 and/or IL-18 RNA level and comparing an IL-8 and/or IL-18 RNA presentation level and a reference transcript presentation level. The technique is implemented by using reverse transcription and a real-time polymerase chain reaction. The ABL and/or HPRT and/or IL lb RNA are used as reference transcripts. The result is considered to be positive if observing a ten times difference of the IL-8 and HPRT RNA presentation levels.
EFFECT: using the declared technique enables early diagnosis of breast cancer.
1 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING BREAST CANCER BY LEVEL OF EXPRESSION OF IL-10 AND/OR IL-17 MRNA IN BLOOD PLASMA | 2020 |
|
RU2752971C1 |
| METHOD FOR DIAGNOSING BREAST CANCER BY LEVEL OF MRNA TGEβ AND TNFα IN BLOOD PLASMA | 2019 |
|
RU2742209C1 |
| METHOD FOR DIAGNOSING BREAST CANCER AND OVARIAN CANCER BY MMP-9 MRNA LEVEL IN BLOOD PLASMA | 2020 |
|
RU2745424C1 |
| METHOD FOR EVALUATING PYORRHOEA ON PARADONTIUM BASED ON LEVEL OF HUMAN INTERLEUKIN-8 (IL-8) GENE MRNA | 2015 |
|
RU2607041C2 |
| DIAGNOSTIC TECHNIQUE FOR BREAST CANCER AND OVARIAN CANCER | 2017 |
|
RU2696114C2 |
| METHOD OF PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH UNRESECTABLE TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2802141C1 |
| METHOD FOR PREDICTING THE DURATION OF A RELAPSE-FREE PERIOD IN PATIENTS WITH RESECTABLE THRICE-NEGATIVE BREAST CANCER | 2021 |
|
RU2780922C1 |
| DIAGNOSTIC TECHNIQUE FOR VAGINITIS IN PREGNANT WOMEN BY INTERLEUKINE GENE IRNA EXPRESSION IN VAGINAL SMEARS | 2011 |
|
RU2510855C2 |
| METHOD OF PRODUCING ANTIGEN-SPECIFIC CYTOTOXIC CELLS HAVING ACTIVITY AGAINST BREAST CANCER CELLS | 2013 |
|
RU2596920C2 |
| METHOD FOR DETERMINING THERAPEUTIC APPROACH IN PATIENTS WITH METASTATIC FORMS AND RECURRENT TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2818730C1 |
